Table of Contents Table of Contents
Previous Page  55 / 114 Next Page
Information
Show Menu
Previous Page 55 / 114 Next Page
Page Background

51

NCCN Guidelines for Patients

®

Breast Cancer - Early-Stage

(STAGES I AND II)

, Version 1.2016

*Preferred and other regimens are based on how well they work, side effects, and treatment schedules.

Chart 4.5 Other regimens*

Other Regimen

Schedule

Total time

Dose-dense AC

Four 14-day cycles

2 months

AC

Four 21-day cycles

3 months

CMF

Six 28-day cycles

6 months

AC

Four 21-day cycles

6 months

then docetaxel

Four 21-day cycles

AC

Four 21-day cycles

6 months

then paclitaxel

Twelve 7-day cycles

EC

Eight 21-day cycles

6 months

FAC

Six 21-day cycles

7 months

then paclitaxel

Twelve 7-day cycles

FEC or CEF

Four 21-day cycles

5 months

then paclitaxel

Eight 7-day cycles

FEC or CEF

Three 21-day cycles

4 months

then docetaxel

Three 21-day cycles

TAC

Six 21-day cycles

4 months

4

Chemotherapy and HER2 inhibitors Regimens: HER-2 negative cancer